Medical Tube Dealers in Kandivali, Mumbai

• Country of Origin: India
• Type: Blood Transfusion Set, Disposable
• Color: Transparent
• Capacity: 0-10ml
• Brand Name: Surgipal
• Packing Type: Individual HM Pack

Product Features: Suitable for intravenous administration of blood and blood component. Sharp spike for smooth penetration. Injection site (Y-Site/ Flash bulb or Latex Tube) Needle: 18 G vein needle. Drop rate 20 drops / ml. Standard Tube length 1.5 mtr. Kink resistant medical grade PVC Tube. Self-sealing latex Bulb. Smooth Roller camp for easy adjustment of flow rate.  Available in single & double drip chamber. Available with or without AIRVENT. Available with Luer lock or luer slip. Non Toxic, pyrogen free disposable ETO Sterile pack.   Packaging Details: Individual HM Pack (25 Pcs Poly) Without Air vent: Box of 400 pcs With Air vent: Box of 300 Pcs

• CATEGORY: Oncology Injectionables
• Dosage: 5mg
• Grade Standard: Medicine Grade
• Storage: Cool and Dry Place
• Form: Tablets / Liquid / Capsules / Powder
• Packaging Type: Plastic Bottle
• Storage: Cool and Dry Place
• Usage: Clinical, hospital etc.

Pamidronate Disodium  IV Infusion BP 30 mg & 60 mg is used in  treatment of moderate to severe hypercalcemia associated with malignancy with or without bone metastases; treatment of moderate to severe Paget disease of bone; treatment of osteolytic bone lesions of multiple myeloma and bone metastases of breast cancer in conjunction with standard chemotherapy. 3s corporation is Supplier,Exporter ,Wholesaler  for Pamidronate Disodium  IV Infusion BP 30 mg & 60 mg in India. India has many manufacturers who manufacture Pamidronate Disodium  IV Infusion BP 30 mg & 60 mg .To know more contact us.     ADDITIONAL INFORMATION Moderate to Severe Hypercalcemia of MalignancyAdults IV For moderate, give 60 to 90 mg as an initial single-dose infusion over 2 to 24 h. For severe, give 90 mg as an initial single-dose infusion over 2 to 24 h. For retreatment, same as initial therapy, at least 7 days after initial dose. Paget DiseaseAdults IV 30 mg/day as a 4-h infusion on 3 consecutive days for a total dose of 90 mg. For retreatment, same as initial therapy, when clinically indicated. Osteolytic Bone Metastases of Breast CancerAdults IV 90 mg as a 2-h infusion every 3 to 4 wk. Osteolytic Bone Lesions of Multiple MyelomaAdults IV 90 mg as a 4-h infusion on a monthly basis.   SIDE EFFECTS CARDIOVASCULAR Atrial fibrillation; atrial flutter; cardiac failure; hypertension; syncope; tachycardia. CNS Asthenia; anxiety; fatigue; headache; insomnia; paresthesia; psychosis; somnolence. DERMATOLOGIC Sweating. ENDOCRINE Hypothyroidism. GI Abdominal pain; anorexia; constipation; diarrhea; dyspepsia; GI hemorrhage; nausea; stomatitis; vomiting. GENITOURINARY UTI; uremia; renal toxicity. HEMATOLOGIC-LYMPHATIC Anemia; granulocytopenia; leukopenia; neutropenia; thrombocytopenia. LAB TESTS Hypocalcemia; hypokalemia; hypomagnesemia; hypophosphatemia. LOCAL Infusion-site reaction. MUSCULOSKELETAL Arthralgia; arthrosis; back pain; bone pain; musculoskeletal pain; myalgia; osteonecrosis primarily of the jaws. RESPIRATORY Coughing; dyspnea; pleural effusion; rales; rhinitis; sinusitis; upper respiratory infection. MISCELLANEOUS Edema; fever; metastases; moniliasis; pain; allergic manifestations (eg, hypotension, dyspnea, angioedema, anaphylactic shock) .

• Material: Non-toxic And Biocompatible PVC
• Size: Length Of The Tube 105 cm.
• Type: Sterile/ Non Sterile
• Packaging Type: Packet and Boxes
• Product Code: DP-GE-VSG-10050